Pnc Financial Services Group, Inc. Bicycle Therapeutics PLC Transaction History
Pnc Financial Services Group, Inc.
- $143 Billion
- Q1 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,700 shares of BCYC stock, worth $152,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,700
Previous 7,560
1.85%
Holding current value
$152,537
Previous $136,000
40.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCYC
# of Institutions
99Shares Held
30.6MCall Options Held
85.5KPut Options Held
11.6K-
Baker Bros. Advisors LP New York, NY4.94MShares$97.9 Million1.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.49MShares$69.1 Million2.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.25MShares$64.3 Million3.03% of portfolio
-
Armistice Capital, LLC New York, NY1.67MShares$33.1 Million0.57% of portfolio
-
Tybourne Capital Management (Hk) LTD Hong Kong, K31.55MShares$30.6 Million8.61% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $588M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...